Compound Detail
CHEMBL1355
SODIUM CITRATE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1355 |
| Name | SODIUM CITRATE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | HRXKRNGNAMMEHJ-UHFFFAOYSA-K |
4
Targets
8
Activities
2
Assay Types
0
PK Parameters
16
Publications
30
Known Names
11
Indications
Molecular Properties
258.1
MW (Da)
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1983 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Anemia Depressive Disorder Dry Eye Syndromes Graft vs Host Disease Uveitis, Anterior Cataract Polycystic Kidney, Autosomal Dominant Venous Thrombosis Diabetes Mellitus, Type 1 Osteoarthritis Propionic Acidemia
ATC Classification
B05CB02
sodium citrate
Level 1: BLOOD AND BLOOD FORMING ORGANS
Level 2: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
Activity Summary
Ki 7 meas. best 7.0
IC50 1 meas. best 4.85
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Carbonic anhydrase 4 CHEMBL3729 | Ki | 7.0 | 7.0 | 99.0 | 1 |
| No relevant target CHEMBL2362975 | IC50 | 4.85 | 4.85 | 14000.0 | 1 |
| Carbonic anhydrase CHEMBL5337 | Ki | 4.41 | 4.41 | 39100.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 4.05 | 4.05 | 88600.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Carbonic anhydrase 4 | Ki | = | 99.0 | nM | 7.0 | Binding affinity against human cytosolic Carbonic anhydrase IV | 15664815 |
| No relevant target | IC50 | = | 14000.0 | nM | 4.85 | Metal chelating activity assessed as Fe2+-compound complex formation incubated f... | 33214834 |
| Carbonic anhydrase | Ki | = | 39100.0 | nM | 4.41 | Inhibition of Candida albicans Nce103 | 19297172 |
| Unchecked | Ki | = | 88600.0 | nM | 4.05 | Inhibition of Cryptococcus neoformans Can2 | 19297172 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 15664815 | 10.1016/j.bmcl.2004.11.057 | Carbonic anhydrase 1 | 1 |
| 15664815 | 10.1016/j.bmcl.2004.11.057 | Carbonic anhydrase 2 | 1 |
| 15664815 | 10.1016/j.bmcl.2004.11.057 | Carbonic anhydrase 4 | 1 |
| 15664815 | 10.1016/j.bmcl.2004.11.057 | Carbonic anhydrase 5A, mitochondrial | 1 |
| 15664815 | 10.1016/j.bmcl.2004.11.057 | Carbonic anhydrase 9 | 1 |
| 19297172 | 10.1016/j.bmc.2009.02.058 | Carbonic anhydrase 2 | 1 |
| 19297172 | 10.1016/j.bmc.2009.02.058 | Unchecked | 1 |
| 19297172 | 10.1016/j.bmc.2009.02.058 | Carbonic anhydrase | 1 |
| - | 10.1039/C2MD20096A | Unchecked | 1 |
| 33214834 | 10.1021/acsmedchemlett.0c00359 | No relevant target | 1 |
| 37360398 | 10.1039/d3md00128h | HGC-27 | 1 |
| 37360398 | 10.1039/d3md00128h | HCT-116 | 1 |
| 37360398 | 10.1039/d3md00128h | HepG2 | 1 |
| 37360398 | 10.1039/d3md00128h | MDA-MB-231 | 1 |
| 37360398 | 10.1039/d3md00128h | SMMC-7721 | 1 |
| 37360398 | 10.1039/d3md00128h | L02 | 1 |
Data from ChEMBL 36 via Core Engine